Related Experiment Video
Updated: Dec 24, 2025
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
17.2K
Congenital diabetes mellitus
Dario Iafusco1, Angela Zanfardino2, Riccardo Bonfanti3
1Department of Pediatrics, University of Campania "Luigi Vanvitelli", Naples, Italy - dario.iafusco@unicampania.it.
Minerva Pediatrica
|April 11, 2020
Summary
Congenital diabetes mellitus, diagnosed before six months of life, presents as transient or permanent forms. Genetic discoveries enable targeted therapies, improving quality of life and potentially reducing complications compared to type 1 diabetes.
Area of Science:
- Pediatrics
- Endocrinology
- Genetics
Background:
- Congenital diabetes mellitus is a rare condition with hyperglycemia onset shortly after birth.
- It is classified as transient (TNDM) or permanent (PNDM), with equal prevalence.
- Clinical features include intrauterine growth retardation, dehydration, and potential associated anomalies.
Purpose of the Study:
- To review the causes, genes, and syndromes associated with congenital diabetes.
- To highlight advancements in understanding pathogenesis and pharmacogenetics.
- To compare congenital diabetes with type 1 diabetes in children.
Main Methods:
- Literature review of congenital diabetes mellitus.
- Analysis of genetic and syndromic causes.
- Examination of therapeutic approaches and clinical outcomes.
Main Results:
- Identified genetic alterations in pancreatic beta-cell potassium channels.
- Demonstrated improved quality of life with oral glibenclamide in specific forms.
- Observed a lower frequency of chronic complications compared to type 1 diabetes.
Conclusions:
- Understanding pathogenesis allows for tailored therapies, such as glibenclamide for potassium channel defects.
- Congenital diabetes offers unique treatment possibilities and a potentially better long-term outlook than autoimmune diabetes.
- Further research in pathogenesis and pharmacogenetics is crucial for this rare condition.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:20Pathophysiology of Diabetes
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
01:20Inborn Errors of Metabolism
630
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
630
01:27Glucose Transporters
27.0K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K